Garner Asset Management Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$603K Buy
503
+23
+5% +$23.5K 0.2% 106
2026
Q1
$441K Sell
480
-40
-8% -$40.6K 0.17% 121
2025
Q4
$559K Hold
520
0.21% 105
2025
Q3
$397K Hold
520
0.16% 122
2025
Q2
$405K Sell
520
-12
-2% -$9.32K 0.19% 117
2025
Q1
$439K Hold
532
0.19% 122
2024
Q4
$411K Buy
532
+12
+2% +$9.94K 0.19% 118
2024
Q3
$461K Sell
520
-20
-4% -$18K 0.2% 114
2024
Q2
$489K Hold
540
0.23% 109
2024
Q1
$420K Hold
540
0.21% 116
2023
Q4
$398K Sell
540
-45
-8% -$26.3K 0.19% 107
2023
Q3
$314K Sell
585
-20
-3% -$10.3K 0.18% 121
2023
Q2
$284K Sell
605
-20
-3% -$8.39K 0.16% 132
2023
Q1
$215K Buy
+625
New +$211K 0.1% 155

Other funds holding LLY

Garner Asset Management Corp's LLY Position: Q2 2026 in Review

Garner Asset Management Corp increased its Eli Lilly (LLY) stake by 4.8% in Q2 2026, buying an estimated $23.5K and bringing the position to 503 shares worth $603K. The position accounts for 0.2% of the portfolio, ranked #106.

Garner Asset Management Corp first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Garner Asset Management Corp held 503 shares of Eli Lilly worth $603K as of Q2 2026.
  • Garner Asset Management Corp bought 23 Eli Lilly shares in Q2 2026, an estimated $23.5K.
  • Eli Lilly made up 0.2% of Garner Asset Management Corp's portfolio in Q2 2026, its #106 holding.
  • Garner Asset Management Corp first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Garner Asset Management Corp's 13F filing for Q2 2026, filed 7 Aug 2026.